NET PROFIT (x1000 EUR)
EMPLOYEES
Acesion Pharma ApS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-7,498
|
-7,490
|
-8,091 |
| Total assets |
15,569
|
22,265
|
7,153 |
| Current assets |
15,378
|
22,018
|
7,142 |
| Current liabilities |
2,512
|
2,831
|
1,576 |
| Equity capital |
12,016
|
17,550
|
3,091 |
| - share capital |
15,447
|
15,462
|
9,480 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.2%
|
78.8%
|
43.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
612.2%
|
777.7%
|
453.2% |
| Return on equity (ROE) |
-62.4%
|
-42.7%
|
-261.8% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.